Oxurion Advances Clinical Data Platform with Acquisition of Axiodis CRO

Oxurion NV, a biopharmaceutical firm based in Leuven, Belgium, has successfully finalized its acquisition of a 72% stake in French clinical data management company Axiodis CRO. This strategic move marks a key milestone in Oxurion's plan to develop an integrated European platform dedicated to clinical data services, including regulatory affairs, data management, e-clinical technologies, and statistical analysis. The company is actively engaging with additional potential partners across France and Europe to expand its clinical data ecosystem, aiming to enhance the efficiency and security of drug development processes. Headquartered in Leuven, Oxurion is transforming from a traditional biopharmaceutical entity into a tech-enabled research organization, focusing on innovative solutions to streamline clinical trials and accelerate therapeutic development. The recent acquisition underscores Oxurion's commitment to building a comprehensive service network in the clinical research sector. For more information, visit www.oxurion.com.